-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.USD↓
Mitarbeiter
7
Virpax Pharmaceuticals, Inc. underperformed den DAX um -52 % vom 17.02.2021 bis 10.08.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Virpax Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Virpax Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Virpax Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Virpax Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
30 News & Informationen zur Virpax Pharmaceuticals, Inc. Aktie
Virpax Pharmaceuticals Announces Poster Presentation For Envelta™ At PAINWeek 2021
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) VRPX, today announced it will present a poster on Leucine Enkephalin as a potential analgesic at
Pre-market Movers: BBIG, AFRM, ATER, SPRT, KPLT, GSAT, ASTR…
The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.36 A.M. EDT)..
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Blue Water Acquisition Corp. (NASDAQ:BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of…
54 Biggest Movers From Yesterday
Gainers Regencell Bioscience Holdings Limited (NASDAQ:RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesd…
10 things before the opening bell
Vials of the Moderna and Pfizer COVID vaccines are seen above in Israel. HAZEM BADER/AFP via Getty Images Welcome to 10 Things Before the Openi…
Pre-market Movers: GOVX, PROG, SONN, MRIN, NVIV…
The following are some of the stocks making big moves in Friday's pre-market trading (as of 5.40 A.M. EDT)..
Pre-market Movers: SONN, ESGC, RSLS, DLO, CHRS, VRPX…
The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.30 A.M. EDT)..
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.08% By Investing.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.08%
Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet
Toward the end of trading Wednesday, the Dow traded down 0.27% to 35,249.25 while the NASDAQ rose 0.06% to 14,664.67. The S&P also fell, dropp…
Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet
Toward the end of trading Wednesday, the Dow traded down 0.27% to 35,249.25 while the NASDAQ rose 0.06% to 14,664.67. The S&P also fell, dropping 0.21% …
Virpax Pharma Jumps After FDA Guidance on Antiviral Masking Spray
Virpax received a pre-investigational new drug response from the FDA for MMS019, an antiviral masking spray it is developing.
Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide
Midway through trading Wednesday, the Dow traded down 0.12% to 35,299.82 while the NASDAQ fell 0.01% to 14,654.93. The S&P also fell, dropping 0.10% to …
Palantir Technologies : Thinking about buying stock in Virpax Pharmaceuticals, Powerbridge Technologies, Sundial Growers, ContextLogic, or Palantir Technologies?
NEW YORK, Aug. 18, 2021 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for VRPX, PBTS, SNDL, WISH, and PLTR.
… | August 18, 2021
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market …
Mid-Morning Market Update: Markets Mixed; Target Reports Upbeat Profit
Following the market opening Wednesday, the Dow traded down 0.12% to 35,300.85 while the NASDAQ rose 0.03% to 14,660.26. The S&P also fell, dropping …
Virpax's stock rockets nearly 5-fold in 2 days after upbeat FDA response to its SARS-CoV-2 inhibitor
Shares of Virpax Pharmaceuticals Inc. undefined rocketed for a second straight day on heavy volume, after the company announced an upbeat pre-investigational…
Wall Street Opens Lower as Covid-19 Fears Weigh Again; Dow Down 150 Pts By Investing.com
Wall Street Opens Lower as Covid-19 Fears Weigh Again; Dow Down 150 Pts
Futures Dip As Traders Await Fed Minutes
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Pre-market Movers: VRPX, GLG, PTIX, GLBS, AMYT, ALC…
The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.32 A.M. EDT)..
66 Biggest Movers From Yesterday
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-i…
VRPX Stock Halted Repeatedly As Shares Rocket Out of Penny Stock Territory
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) more than tripled today on FDA-related news about its anti-viral barrier product.
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0…
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.
Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market …
Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019
Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019 | Nachricht | finanzen.net
(NASDAQ:VRPX)Virpax Pharmaceuticals adds Gerald Bruce and Michael Dubin to board
Virpax Pharmaceuticals (VRPX) announces the appointment of Gerald Bruce and Michael Dubin to the company's board of directors.Bruce has spent over 30 years, including 20 years in…
Virpax® Pharmaceuticals Strengthens Board Of Directors With The Appointment Of Gerald W. Bruce And Michael F. Dubin, CPA To Its Board
Virpax ® Pharmaceuticals Inc. (“Virpax” or the “Company”) VRPX, a company specializing in developing pharmaceutical product candidates for pain management,
Pre-market Movers: ATHE, HUDI, VERB, SGOC, IMUX…
The following are some of the stocks making big moves in Thursday's pre-market trading (as of 4.43 A.M. EDT)..
64 Biggest Movers From Yesterday
Gainers Allied Healthcare Products, Inc. (NASDAQ:AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday. Red Cat Holdings, Inc. (NASDAQ:RCAT)…
Virpax Pharmaceuticals : Provides Progress Update on Product Candidates
Virpax® Pharmaceuticals Inc. , today is providing a progress update on its pipeline of product candidates following the Company’s initial public offering in mid-February of… | July 7, 2021
Virpax To Use Envelta™ IND Enabling Study Results For Two Additional Indications
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) VRPX, today announced that the Investigational New Drug (IND) Application enabling studies for